Publication | Closed Access

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

Harm ReductionHealth EconomicsHealth PolicyDrug PolicyOutcomes ResearchPharmacoeconomicsHealth Care FinancePublic HealthEconomic EvaluationMedicineAdverse Health OutcomesAdverse Drug ReactionHealth Services ResearchPharmacoepidemiologyDrug Pricing